Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 Infratentorial Neoplasms 1 Ependymoma 1 Brain Neoplasms 1

Interventions

X-Rays 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Cyclophosphamide 4 Biopsy 4 Topotecan 3 Etoposide 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Vincristine 2 Nivolumab 2 Methotrexate 2 Ipilimumab 2 Cisplatin 2 Carboplatin 2 pembrolizumab 1 olaparib 1 atezolizumab 1 Vinblastine 1 Vemurafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rhabdoid Tumor × Craniospinal Irradiation × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡